Stocksigma LogoStocksigma Logo

Promoter Increases Stake in Goldline Pharmaceutical

Amol Laxmikant Mujumdar, Promoter and Managing Director, acquired 60,000 equity shares (0.62% of total capital) via an open market purchase on 31 Aug'26

Promoter Increases Stake in Goldline Pharmaceutical

Goldline Pharmaceutical Ltd 路 Acquisition/ Disposal of Shares 路 01 Sept 2026, 6:41 pm

Promoter Increases Stake in Goldline Pharmaceutical Amol Laxmikant Mujumdar, Promoter and Managing Director, acquired 60,000 equity shares (0.62% of total capital) via an open market purchase on 31 Aug'26. This transaction increases his total shareholding from 2,749,988 shares (28.64%) to 2,809,988 shares (29.27%). The purchase signals strengthened promoter confidence. The company's total issued capital remains at 9,600,000 equity shares post-acquisition. This disclosure was made under SEBI (SAST) Regulations, 2011.

Original exchange filing (PDF)

More announcements from Goldline Pharmaceutical Ltd

All Goldline Pharmaceutical Ltd announcements